VIDEO: Active surveillance for prostate cancer
In these videos, H. Ballentine Carter, MD, discusses the evidence supporting active surveillance, and Leonard S. Marks, MD, and colleagues outline which men are good candidates for surveillance.
Active surveillance for prostate cancer is the subject of the most recent installment in Urology Times' ongoing "New Frontiers in Prostate Cancer" series.
In these videos, H. Ballentine Carter, MD, discusses the evidence supporting active surveillance, and Leonard S. Marks, MD, and colleagues outline which men are good candidates for surveillance.
More on Prostate Cancer/Active Surveillance
Diagnosing docs strongly influence PCa Tx decisions
Clinicians say active surveillance is effective but rarely recommend it
Nomogram may lower unneeded biopsies in men on AS
One-fourth of men drop out of prostate cancer surveillance
RP edges observation in young men with prostate cancer
Subscribe to Urology Times to get monthly news from the leading news source for urologists.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.
